201 related articles for article (PubMed ID: 26357501)
41. Lipiodol: a potential direct surrogate for cone-beam computed tomography image guidance in radiotherapy of liver tumor.
Yue J; Sun X; Cai J; Yin FF; Yin Y; Zhu J; Lu J; Liu T; Yu J; Shi X; Song J
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):834-41. PubMed ID: 21377291
[TBL] [Abstract][Full Text] [Related]
42. Local recurrence of hepatocellular carcinoma after segmental transarterial chemoembolization: risk estimates based on multiple prognostic factors.
Park SH; Cho YK; Ahn YS; Park YO; Kim JK; Chung JW
Korean J Radiol; 2007; 8(2):111-9. PubMed ID: 17420628
[TBL] [Abstract][Full Text] [Related]
43. Balloon-Occluded Trans-Arterial Chemoembolization Technique with Alternate Infusion of Cisplatin and Gelatin Slurry for Small Hepatocellular Carcinoma Nodules Adjacent to the Glisson Sheath.
Irie T; Takahashi N; Kamoshida T
Biomed Res Int; 2019; 2019():8350926. PubMed ID: 31211142
[TBL] [Abstract][Full Text] [Related]
44. Local recurrence after chemoembolization of hepatocellular carcinoma: uptake of gadoxetic acid as a new prognostic factor.
Ishimaru H; Nakashima K; Sakugawa T; Sakamoto A; Matsuoka Y; Ashizawa K; Uetani M
AJR Am J Roentgenol; 2014 Apr; 202(4):744-51. PubMed ID: 24660701
[TBL] [Abstract][Full Text] [Related]
45. Transarterial chemoembolization with cisplatin as second-line treatment for hepatocellular carcinoma unresponsive to chemoembolization with epirubicin-Lipiodol emulsion.
Maeda N; Osuga K; Higashihara H; Tomoda K; Mikami K; Nakazawa T; Nakamura H; Tomiyama N
Cardiovasc Intervent Radiol; 2012 Feb; 35(1):82-9. PubMed ID: 21203761
[TBL] [Abstract][Full Text] [Related]
46. Lipiodol versus diaphragm in 4D-CBCT-guided stereotactic radiotherapy of hepatocellular carcinomas.
Chan MK; Lee V; Chiang CL; Lee FA; Law G; Sin NY; Siu KL; Wong FC; Tung SY; Luk H; Blanck O
Strahlenther Onkol; 2016 Feb; 192(2):92-101. PubMed ID: 26636141
[TBL] [Abstract][Full Text] [Related]
47. Dense accumulation of lipiodol emulsion in hepatocellular carcinoma nodule during selective balloon-occluded transarterial chemoembolization: measurement of balloon-occluded arterial stump pressure.
Irie T; Kuramochi M; Takahashi N
Cardiovasc Intervent Radiol; 2013 Jun; 36(3):706-13. PubMed ID: 22996589
[TBL] [Abstract][Full Text] [Related]
48. Predisposing factors of hepatocellular carcinoma recurrence following complete remission in response to transarterial chemoembolization.
Jin YJ; Chung YH; Kim JA; Park W; Lee D; Shim JH; Lee D; Kim KM; Lim YS; Lee HC; Lee YS; Kim PN; Sung KB
Dig Dis Sci; 2013 Jun; 58(6):1758-65. PubMed ID: 23361574
[TBL] [Abstract][Full Text] [Related]
49. [Chemoembolization of hepatocellular carcinomas: which factors determine therapeutic response and survival?].
Huppert PE; Lauchart W; Duda SH; Torkler C; Kloska SP; Weinlich M; Benda N; Pereira P; Claussen CD
Rofo; 2004 Mar; 176(3):375-85. PubMed ID: 15026951
[TBL] [Abstract][Full Text] [Related]
50. Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response.
Dioguardi Burgio M; Sartoris R; Libotean C; Zappa M; Sibert A; Vilgrain V; Ronot M
Cancer Imaging; 2019 Nov; 19(1):75. PubMed ID: 31730491
[TBL] [Abstract][Full Text] [Related]
51. Transarterial Alcohol-Lipiodol Therapy in Patients with Hepatocellular Carcinoma Using Low Alcohol Concentrations.
Mohné F; Meyer C; Kuhl CK; Pieper CC; Schild HH
Rofo; 2016 Jul; 188(7):676-83. PubMed ID: 27248649
[TBL] [Abstract][Full Text] [Related]
52. Adjuvant I-131 Lipiodol After Resection or Radiofrequency Ablation for Hepatocellular Carcinoma.
Schwarz L; Bubenheim M; Gardin I; Huet E; Riachi G; Clavier E; Goria O; Vera P; Scotté M
World J Surg; 2016 Aug; 40(8):1941-50. PubMed ID: 27098539
[TBL] [Abstract][Full Text] [Related]
53. Risk factors for local tumor recurrence after segmental transarterial chemoembolization for hepatocellular carcinoma: the importance of tumor located in the segmental border zone.
Cho YK; Chung JW; Ahn YS; Park YO; Kim JK; Byun JH
Korean J Radiol; 2006; 7(4):267-74. PubMed ID: 17143030
[TBL] [Abstract][Full Text] [Related]
54. Iodized oil uptake assessment with cone-beam CT in chemoembolization of small hepatocellular carcinomas.
Jeon UB; Lee JW; Choo KS; Kim CW; Kim S; Lee TH; Jeong YJ; Kang DH
World J Gastroenterol; 2009 Dec; 15(46):5833-7. PubMed ID: 19998505
[TBL] [Abstract][Full Text] [Related]
55. MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Kloeckner R; Otto G; Biesterfeld S; Oberholzer K; Dueber C; Pitton MB
Cardiovasc Intervent Radiol; 2010 Jun; 33(3):532-40. PubMed ID: 19847482
[TBL] [Abstract][Full Text] [Related]
56. Using intravoxel incoherent motion (IVIM) MR imaging to predict lipiodol uptake in patients with hepatocellular carcinoma following transcatheter arterial chemoembolization: a preliminary result.
Park YS; Lee CH; Kim JH; Kim IS; Kiefer B; Seo TS; Kim KA; Park CM
Magn Reson Imaging; 2014 Jul; 32(6):638-46. PubMed ID: 24703575
[TBL] [Abstract][Full Text] [Related]
57. [Chemoembolization in hepatocellular carcinoma: multivariate analysis of survival prognostic factors after the first session].
El Khaddari S; Gaudin JL; Abidi H; Picaud G; Rode A; Souquet JC
Gastroenterol Clin Biol; 2002; 26(8-9):728-34. PubMed ID: 12434077
[TBL] [Abstract][Full Text] [Related]
58. Effectiveness of intraprocedural dual-phase cone-beam computed tomography in detecting hepatocellular carcinoma and improving treatment outcomes following conventional transarterial chemoembolization.
Cho Y; Lee S; Park SJ
PLoS One; 2021; 16(1):e0245911. PubMed ID: 33513172
[TBL] [Abstract][Full Text] [Related]
59. Outpatient Transarterial Chemoembolization of Hepatocellular Carcinoma: Review of a Same-Day Discharge Strategy.
Fritsche MR; Watchmaker JM; Lipnik AJ; Baker JC; Geevarghese S; Banovac F; Omary RA; Brown DB
J Vasc Interv Radiol; 2018 Apr; 29(4):550-555. PubMed ID: 29478795
[TBL] [Abstract][Full Text] [Related]
60. Transarterial chemoembolization (TACE) using mitomycin and lipiodol with or without degradable starch microspheres for hepatocellular carcinoma: comparative study.
Gruber-Rouh T; Schmitt C; Naguib NNN; Nour-Eldin NA; Eichler K; Beeres M; Vogl TJ
BMC Cancer; 2018 Feb; 18(1):188. PubMed ID: 29444653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
